Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® ENFORM Biomaterial Product Study

NCT: NCT04718168 · RECRUITING

NCT IDNCT04718168
StatusRECRUITING
Start Date2021-05-17
Completion2026-09
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, retrospective, non-randomized, multicenter study with two independent hernia study cohorts (Ventral / Incisional Hernia Repair and Diaphragmatic / Hiatal Hernia Repair). The primary objective of this study is to collect GORE® ENFORM Biomaterial product commercial-use data on device functional performance and short-term patient experience.

Frequently Asked Questions

What is GORE® ENFORM Biomaterial Product Study?

GORE® ENFORM Biomaterial Product Study is a clinical trial registered under NCT04718168. Current status: RECRUITING.

What is the status of NCT04718168?

The current status of NCT04718168 (GORE® ENFORM Biomaterial Product Study) is: RECRUITING.

When did GORE® ENFORM Biomaterial Product Study start?

GORE® ENFORM Biomaterial Product Study started on 2021-05-17.

Related Devices

K173333GORE ENFORM BiomaterialW. L. Gore & Associates, Inc. K163576GORE SYNECOR Preperitoneal BiomaterialW. L. Gore & Associates, Inc. K170740GORE VIABIL Short Wire Biliary EndoprosthesisW. L. Gore & Associates, Inc. K160254GORE DrySeal Flex Introducer SheathW. L. Gore & Associates, Inc. K163217GORE BIO-A Tissue ReinforcementW. L. Gore & Associates, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑